XOMA Royalty (XOMA) EBIT Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) EBIT Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.49 Mn |
-60.59 Mn |
- |
-108.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
-108.10% |
| Dec 31, 2025 |
65.24% |
| Sep 30, 2025 |
91.50% |
| Jun 30, 2025 |
145.67% |
| Mar 31, 2025 |
184.65% |
| Dec 31, 2024 |
63.61% |
| Sep 30, 2024 |
-170.26% |
| Jun 30, 2024 |
-69.20% |
| Mar 31, 2024 |
31.13% |
| Dec 31, 2023 |
-221.00% |
| Sep 30, 2023 |
-32.37% |
| Jun 30, 2023 |
-24.96% |
| Mar 31, 2023 |
-392.49% |
| Dec 31, 2022 |
-120.45% |
| Sep 30, 2022 |
-30.70% |
| Jun 30, 2022 |
-55.58% |
| Mar 31, 2022 |
67.87% |
| Dec 31, 2021 |
27.20% |
| Sep 30, 2021 |
-24.40% |
| Jun 30, 2021 |
2.76% |
